ARHS three-lens brief
Evidence-based stock research on ARHS. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved -2.22% yesterday. · Trading at 94% of its 52-week range — near the top of the band.
- Moved -2.22% yesterday.
- Trading at 94% of its 52-week range — near the top of the band.
- 50-day MA above 200-day MA (golden-cross regime); price above both.
- RSI at 73 — technically overbought.
- Outperforming SPY by 54.1pp over 30 days.
ARHS closed at $14.56 (-2.22%) as of 2026-11-12. Market cap: $2.06B. P/E (trailing) 31.7. Price is above the 50-day MA and above the 200-day MA. Positives: 50-day MA above 200-day MA (golden-cross regime); price above both.; outperforming SPY by 54.1pp over 30 days.. Concerns: moved -2.22% yesterday.; trading at 94% of its 52-week range — near the top of the band.. Last quarter: Revenue $368.12M, net income $7.82M, free cash flow $161.66M.
Why three lenses on ARHS, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ARHS across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/ARHS" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ARHS brief"></iframe>